UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT (FILE NO. 333-81009)

UNDER

THE SECURITIES ACT OF 1933

 

 

Nabi Biopharmaceuticals

(Exact name of registrant as specified in charter)

 

 

 

Delaware		59-1212264
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

12276 Wilkins Avenue

Rockville, MD 20852

(301)770-3099

(Address, including zip code, and telephone number, including

area code, of registrant’s principal executive offices)

 

Rafaat E.F. Fahim Chief Executive Officer and President Nabi Biopharmaceuticals 12276 Wilkins Avenue Rockville, MD 20852 (301)770-3099		Copy to: James E. Dawson, Esq. Nutter, McClennen & Fish, LLP 155 Seaport Boulevard Boston, MA 02210 (617) 439-2000
(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer		¨		Accelerated filer		x
Non-accelerated filer		¨  (Do not check if a smaller reporting company)		Smaller reporting company		¨

 

 

 

---

Deregistration of Unsold Securities

Pursuant to Registration Statement on Form S-8 (File No. 333-81009) (the “Registration Statement”) filed with the Securities and Exchange Commission (the “SEC”) on June 18, 1999 by Nabi Biopharmaceuticals (the “Company”), the Company registered 150,000 shares (the “Securities”) of the Company’s common stock, par value $.10 per share (the “Securities”), issuable pursuant to its Stock Plan for Non-Employee Directors (the “Plan”). The Company has ceased issuing Securities under the Plan.

The Company seeks to deregister the Securities that remain unissued under the Registration Statement as of the date hereof. Pursuant to the undertaking of the Company contained in the Registration Statement pursuant to Item 512(a)(3) of Regulation S-K, the Company is filing this Post-Effective Amendment No. 1 to the Registration Statement to deregister the Securities remaining unissued under the Registration Statement.

---

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rockville, State of Maryland, on the 22^nd day of May, 2009.

 

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints Raafat Fahim and James E. Dawson, and each of them, with full power to act without the others, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in his or her name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this registration statement and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary or advisable to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933 this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated, as of May 22, 2009.

 

Signatures		Title
/s/    Raafat E.F. Fahim, Ph.D Raafat E.F. Fahim, Ph.D		President, Chief Executive Officer, acting Chief Financial Officer and Director
/s/    Ronald B. Kocak Ronald B. Kocak		Corporate Controller and Chief Accounting Officer
/s/    Geoffrey F. Cox, Ph.D. Geoffrey F. Cox, Ph.D.		Chairman of the Board
/s/    Jason Aryeh Jason Aryeh		Director
/s/    David L. Castaldi David L. Castaldi		Director
/s/    Peter B. Davis Peter B. Davis		Director
/s/    Richard A. Harvey, Jr. Richard A. Harvey, Jr.		Director
/s/    Linda Jenckes Linda Jenckes		Director
/s/    Timothy Lynch Timothy Lynch		Director
/s/    Stephen G. Sudovar Stephen G. Sudovar		Director